DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogrammingXuejiao Yang, Yueying Wang, Yunshuo Chen et al.|Journal of Translational Medicine|2023Cited by 12
NAM-NAD+-ADO metabolic reprogramming is a key factor for DNMT3A mutation to promote leukemia development through regulating cell cycle and immune microenvironmentYueying Wang, Siqi Shang, Xuejiao Yang et al.|Research Square|2022Cited by 0